$486 Million is the total value of Foresite Capital Management IV, LLC's 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | $171,382,000 | -23.0% | 9,671,643 | 0.0% | 35.26% | +7.6% | |
| LYEL | Lyell Immunopharma, Inc. | $102,804,000 | -47.7% | 13,282,181 | 0.0% | 21.15% | -26.9% | |
| ACRS | Aclaris Therapeutics, Inc. | $49,422,000 | -19.2% | 3,399,034 | 0.0% | 10.17% | +12.9% | |
| PHVS | Pharvaris N.V. | $46,939,000 | -18.8% | 3,261,926 | 0.0% | 9.66% | +13.4% | |
| QSI | Quantum-Si Incorporated | $35,129,000 | -5.6% | 4,463,619 | 0.0% | 7.23% | +31.8% | |
| NRIX | Nurix Therapeutics, Inc. | $34,908,000 | -3.4% | 1,205,798 | 0.0% | 7.18% | +35.0% | |
| KURA | Kura Oncology, Inc. | $25,899,000 | -25.3% | 1,849,947 | 0.0% | 5.33% | +4.4% | |
| Cue Health Inc. | $13,492,000 | +13.5% | 1,006,089 | 0.0% | 2.78% | +58.6% | ||
| CBAY | Cymabay Therapeutics, Inc. | $6,040,000 | -7.4% | 1,787,094 | 0.0% | 1.24% | +29.3% | |
| DBTX | Exit | Decibel Therapeutics, Inc. | $0 | – | -297,711 | -100.0% | -0.34% | – |
| TPST | Exit | Tempest Therapeutics, Inc. | $0 | – | -190,213 | -100.0% | -0.40% | – |
| OLMA | Exit | Olema Pharmaceuticals, Inc. | $0 | – | -342,030 | -100.0% | -1.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 23 | Q3 2023 | 14.8% |
| Aclaris Therapeutics, Inc. | 18 | Q3 2023 | 18.9% |
| Kura Oncology, Inc. | 16 | Q3 2023 | 11.7% |
| Kinnate Biopharma Inc. | 12 | Q3 2023 | 41.8% |
| Myokardia, Inc. | 12 | Q3 2020 | 17.8% |
| Pharvaris N.V. | 11 | Q3 2023 | 43.4% |
| Cytokinetics Incorporated | 11 | Q2 2021 | 31.6% |
| Lyell Immunopharma, Inc. | 10 | Q3 2023 | 29.2% |
| Insmed Incorporated | 10 | Q1 2020 | 19.2% |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | Q1 2020 | 14.5% |
View Foresite Capital Management IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 4 | 2023-05-10 |
| 4 | 2023-02-22 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
View Foresite Capital Management IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.